Overview

Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy of long-term application of Shenyankangfu Tablets in Large sample of patients with chronic kidney disease.
Phase:
Phase 4
Details
Lead Sponsor:
Chen Xiangmei
Collaborator:
Tianjin TongRenTang Group Co., Ltd.